Genentech Keeping Pipeline Full; Biotech Developing Drugs For Cancer, Blindness.(THE IBD 100)

Publication: Investor's Business Daily

Bookmark this article Print this article Link to this article Email this article Digg It! Add to del.icio.us RSS

COPYRIGHT 2005 Investor's Business Daily, Inc.

Byline: Juan Carlos Arancibia

Ask someone at Genentech what they're working on and they may reply with something like a treatment for intermediate grade or aggressive CD-20-Positive, B-cell, non-Hodgkin's lymphoma.

Whatever the technical terms may be, the company is a leading researcher into treatments for cancer, cystic fibrosis, asthma...

Read the full article for free courtesy of your local library.